Camille Ponté

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance

Marine Tambon, Camille Ponté, Émilie Jouanjus et al. · Frontiers in Psychiatry · 2021 · 58 citations · Full text

Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database

Jean‐Baptiste Bossard, Camille Ponté, Julie Dupouy et al. · Clinical Drug Investigation · 2016 · 42 citations

Drug Safety, Substance Abuse, Disproportionality Analysis +13

Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries

Camille Ponté, Marion Lepelley, Quentin Boucherie et al. · Drug and Alcohol Dependence · 2018 · 39 citations

Opioid Analgesics, Opioid Epidemic, Substance Abuse +13

Early signal of diverted use of tropicamide eye drops in France

Camille Ponté, Christian Pi, Aurore Palmaro et al. · British Journal of Clinical Pharmacology · 2017 · 25 citations · Full text

Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey

Léna Blayac, Camille Ponté, Monique Lavaud et al. · Therapies · 2022 · 13 citations

Substance Abuse, Substance Use, Addiction +11